Skip to main content
. 2013 Feb 10:76–83.e3. doi: 10.1016/B978-1-4377-2702-9.00008-8

TABLE 8-2.

Schedule and Dosing for Travel Vaccines

Vaccine Schedule Minimum Age Dose (mL) Route Booster Dose
BCG (live attenuated) 1 dose Birth <30 days: 0.3 mL (dilute to half concentration)
>30 days: 0.3 mL
Intradermal preferred but subcutaneous acceptable None

Hepatitis A/B, combined (inactivated/recombinant) 3 doses: 0, 1, and 6 months 1 year 0.5 mL Intramuscular None

Meningococcal – A/C/Y/W-135 (polysaccharide) 1 dose 3 months (see text) 0.5 mL Subcutaneous <4 years: 2–3 years
≥4 years: 3–5 years

Meningococcal – A/C/Y/W-135 (conjugated polysaccharide) 1 dose 2 years 0.5 mL Intramuscular <7 years: 3 years
≥7 years: 5 years

Rabies (inactivated cell culture) 3 doses: 0, 7, 21 or 28 days Birth 1.0 mL Intramuscular Consider at 2 years if high-risk

Typhoid, Ty21a (live attenuated) 4 doses: alternate days 6 years 1 capsule Oral 5 years

Typhoid, Vi (capsular polysaccharide) 1 dose 2 years 0.5 mL Intramuscular 2 years

Yellow fever (live attenuated) 1 dose 9 months 0.5 mL Subcutaneous 10 years

Japanese encephalitis (IXIARO) 2 doses: 0 and 28 days 17 years 0.5 mL Intramuscular 1 year

BCG, bacille Calmette-Guérin